Craniotomy for Intracranial Tumors: Role of Postoperative Hematoma in Surgical Mortality

 

N

%

Patients

2,630

100

Sex

 Male

1,275

48.5

 Female

1,355

51.5

Age (years)

 18–29.9

141

5.4

 30–39.9

300

11.4

 40–49.9

437

16.6

 50–59.9

604

23.0

 60–69.9

649

24.7

 70–79.9

411

15.6

 > 80

88

3.3

Type of surgery

 Primary

2,141

81.4

 Second

489

18.6

Craniotomy
  
 Resection

2,556

97.2

 Open biopsy

74

2.8

Main histology

 High-grade glioma (HGG)

830

31.6

 Meningioma

693

26.3

 Metastases

449

17.1

 Low-grade glioma (LGG)

289

11.0

 Schwannoma

73

2.8

 Primary CNS-lymphoma

51

1.9

 CNS hemangioblastoma

39

1.5

 Cavernous hemangioma

38

1.4

 Pituitary adenoma

8

0.3

 Others

160

6.1





Perioperative Craniotomy Routines


A consultant anesthetist should see all craniotomy patients preoperatively. Elderly patients (> 70 years) and patients on multiple medications should routinely also seen by consultant internist, to optimize the general medical condition and medications. At our institution, patients with a known heart condition are referred to cardiologist for cardiac ultrasound and ECG stress test. Patients with a past hematological history are referred to a consultant hematologist. Aspirin, dipyridamole and clopidogrel are stopped at least 10 days prior to surgery and when on anticoagulation, the INR should be below 1.5. All patients receive compressive stockings the day before surgery and keep them until fully mobilized. Postoperatively, the patients are observed in the recovery for 3–6 h, whereafter they are transferred to a level 2 bed. After a craniotomy for a supratentorial tumor, the patients are generally observed for 24 h. For infratentorial tumors, the length of observation is minimum 48 h Low-molecularweight heparin is given the first postoperative day. The patients are mobilized either in the afternoon at the day of surgery or on the first postoperative day.


Incidence of Craniotomies


First-time craniotomies with primary resection were performed in 2,073 cases, 483 cases were reoperations with repeated resection, and 74 cases were open biopsies. Thus, the incidence of first-time craniotomy for a brain tumor was 12.8/100,000 inhabitants per year and for a repeat resection 3.0/100,000 inhabitants per year.


Surgical Mortality


The surgical mortality, defined as death within 30 days of surgery, was 2.3 % (n = 60). In 21 cases, the cause of death was postoperative hematomas (35.0 %). In the remaining patients, the cause of death was either tumor progression (35.0 %), infectious diseases (13.3 %), postoperative edema and subsequent herniation (6.7 %), and other causes in 10 % (Table 17.2). Using multivariate Cox regression analyses, age > 60 (Odds ratio (OR) 1.84, 95 % CI (1.05, 3.22), p < 0.05) and biopsy compared to resection (OR 4.67, 95 % CI (1.80, 12.14) p < 0.01) were shown to be significantly associated with increased surgical mortality (Table 17.3).


Table 17.2
Surgical mortality: patients who died within 30 days of tumor surgery (n = 60)






















































































































































































































































































































































































































































Age

Sex

Histologya

Op.typeb

Timec

Comments

43

M

Hemangioblastoma

R

3

Postop. hematoma

29

F

HGG

R

17

Tumor progression

41

M

HGG

R

13

Postop. brain edema/herniation

41

F

HGG

R

3

Postop. hematoma

48

M

HGG

B

10

Pneumonia

49

F

HGG

R

11

Tumor progression

54

F

HGG

R

2

Tumor progression

56

F

HGG

B

8

Postop. hematoma

60

M

HGG

R

30

Postop. hematoma

64

M

HGG

R

17

Tumor progression

64

F

HGG

R

4

Postop. brain edema/herniation

65

F

HGG

R

22

Postop. hematoma

66

F

HGG

R

24

Tumor progression

67

F

HGG

R

5

Tumor progression

67

M

HGG

R

19

Tumor progression

69

M

HGG

B

29

Tumor progression

74

F

HGG

R

30

Tumor progression

75

M

HGG

R

11

Postop. hematoma

75

M

HGG

R

22

Tumor progression

76

M

HGG

R

15

Postop. hematoma

76

F

HGG

R

4

Postop. hematoma

77

F

HGG

R

8

Postop. hematoma

81

F

HGG

B

28

Tumor progression

82

M

HGG

R

21

Pulmonary embolism

84

F

HGG

R

14

Postop. brain edema/herniation

32

F

LGG

R

17

Shunt failure

48

M

LGG

R

18

Pneumonia

68

M

LGG

R

24

Postop. hematoma

62

M

Lymphoma

B

12

Tumor progression

75

F

Lymphoma

B

13

Tumor progression

78

M

Lymphoma

B

26

Tumor progression

31

F

Melanocytoma

R

11

Tumor progression

55

F

Meningioma

R

6

Postop. brain edema/herniation

73

M

Meningioma

R

11

Postop. hematoma

77

M

Meningioma

R

4

Postop. hematoma

79

F

Meningioma

R

12

Postop. hematoma

83

M

Meningioma

R

15

Pneumonia

83

M

Meningioma

R

29

Cardiac arrest

35

M

Metastasis

R

12

Tumor progression

40

M

Metastasis

R

27

Pneumonia

45

F

Metastasis

R

4

Postop. hematoma

46

F

Metastasis

R

9

Hydrocephalus

49

F

Metastasis

R

25

Postop. hematoma

49

F

Metastasis

R

26

Postop. hematoma

52

M

Metastasis

R

6

Postop. hematoma

53

F

Metastasis

R

5

Tumor progression

56

M

Metastasis

R

3

Cardiac arrest

60

M

Metastasis

R

1

Postop. hematoma

61

M

Metastasis

R

30

Postop. hematoma

61

F

Metastasis

R

12

Pneumonia

62

M

Metastasis

R

19

Tumor progression

62

M

Metastasis

R

29

Postop. hematoma

65

F

Metastasis

R

22

Sepsis

71

F

Metastasis

R

25

Tumor progression

73

M

Metastasis

R

24

Sepsis

77

F

Metastasis

R

19

Tumor progression

78

M

Metastasis

R

29

Subdural empyema

81

F

Metastasis

R

25

Tumor progression

48

M

Pituitary adenoma

R

16

Cerebral infarction

69

M

Pituitary adenoma

R

9

Postop. hematoma

Mar 17, 2017 | Posted by in NEUROLOGY | Comments Off on Craniotomy for Intracranial Tumors: Role of Postoperative Hematoma in Surgical Mortality

Full access? Get Clinical Tree

Get Clinical Tree app for offline access